链桥I单元2025年季度报告

PARTI. FINANCIAL INFORMATIONCondensed Interim Financial StatementsCondensed Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024Unaudited Condensed Statements of Operations for the three months ended March 31, 2025 and 2024Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the three months ended March 31,2025 and 2024Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2025 and 2024Notesto Unaudited Condensed Interim Financial StatementsManagement’s Discussion and Analysis of Financial Condition and Results of OperationsQuantitative and Qualitative Disclosures About Market Risk For the Three MonthsEndedMarch31,2025 EndedMarch 31,2025 Cash Flows from Investing Activities: Cash withdrawn from Trust Account in connection with redemption—34,530,235Cash deposited in Trust Account(13,672)Net cash (used in) provided by investing activities(13,672)34,507,735 Proceeds from Fulton AC Note—Repayment of bridge financing note(40,000)Redemption of Class A ordinary shares—(34,530,235Net cash used in financing activities(26,328)(34,357,416) Cash — beginning of the period129,598Cash — end of the period$17,565$ Waiver of $100,000dissolution expense pursuant to Dissolution Expense ReimbursementAgreement$100,000$The accompanying notes are an integral part of these unaudited condensed interim financial statements. 4 Chain Bridge I (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 21,2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income oncash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected a December 31stfiscal year end.The registration statement for the Company’s Initial Public Offering was declared effective on November 9, 2021. On November 15,2021, the Company consummated its Initial Public Offering of23,000,000units (the “Units” and, with respect to the Class A ordinaryshares included in the Units being offered, the “Public Shares”), including3,000,000additional Units to cover over-allotments (the“Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs ofapproximately $5.7million, of which approximately $254,000was for offering costs allocated to derivative warrant liabilities.Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Company’s initial Business Combination, or, at the discretion of CBG, converted into additional warrants at a price of $1.00perwarrant, which warrants will be identical to the Private Placement Warrants. The Additional Convertible Note was terminated onDecember 29, 2023.Upon the closing of the Initial Public Offering, $234.6million ($10.20per Unit) of net proceeds, including the net proceeds of the conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasuryobligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distributionof the Trust Account as described below.5 CBG, and CB Co-Investment entered into non-redemption agreements with several unaffiliated third parties in exchange for such thirdparties agreeing not to redeem an aggregate of4,000,000ordinary shares of the Company sold in its Initial Public Offering at anextraordinary general meeting of its shareholders held on May 12, 2023 (the “Special Meeting”). In exchange for the foregoingcommitments not to redeem such shares, CBG and CB Co-Investment, as applicable, agreed to transfer to such third parties anaggregate of1,000,000ordinary shares of the Company held by CBG or CB Co-Investment, as applicable, plus up to an additional Business Combination. Such transfer of ordinary shares of the Company shall be effected immediately following the consummation ofthe Company’s initial Business Combination if such third party or third parties continued to hold such shares through the Special exercised their right to redeem their shares for an aggregate of approximately $197,854,025in cash held in the Trust Account.At the Special Meeting, the shareholders of the Company approved the amendment to the Company’s amended and restatedmemorandum and articles of incorporation (as amended from time to time, the “Amended and Restated Memorandum and Articles ofAssociation”), which extended the date to consummate a Business Combination from May 15, 2023 to November 15, 2023, andallowed the board of directors of the Company (the “Board”), without another shareholder vote, to elect to further extend the date to which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1million (th